Financial Daily from THE HINDU group of publications
Wednesday, Nov 09, 2005


Group Sites

Corporate - Announcements
Marketing - IPR

RPG Life Sciences gets US patent for Risperidone

Our Bureau

Mumbai , Nov. 8

RPG Life Sciences Ltd has got a US patent for its novel process of producing Risperidone, a pharmaceutical ingredient used in anti-psychotic medicines.

RPG Life Sciences already has similar patents for Risperidone in the UK, Germany, France, Switzerland and other European markets, the company told the BSE.

Risperidone is an atypical antipsychotic medication used to treat symptoms of schizophrenia. The medication decreases the abnormal excitement in the brain.

The global market for the formulations of Risperidone is estimated to be over $2 billion. The company already sells Risperidone in Spain, India and other developing countries.

It expects to enter other regulated markets when the patent on the product expires.

The product patent expires in Europe in early-2007 and in the US in late 2007 or early 2008, a company official said.

It already supplies the ingredient to other Indian companies. Formerly Searle India, RPG Life Sciences operates in the domestic and international markets with a presence in the therapeutic areas including cardiovascular, central nervous system, anti-diabetic, anti-cancer, immuno-suppressants, anti-infective and anti-inflammatory segments.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Tata Safari Dicor

Stories in this Section
BILT to set up stationery outlets — To leverage retail brands Matrix, Royal Executive Bond

RPG Life Sciences gets US patent for Risperidone
AIA Engg IPO price band set at Rs 275-315
No communication from UN, says Tata International
BEML pays Rs 19.12-cr dividend
Coromandel Cements pref offer
Welspun-Gujarat raises $75 m thru FCCBs
Bhagyanagar Metals, Surana Tele to undergo demerger, restructuring
ICI to hive off rubber chemicals biz to jt venture with US co
Dr Reddy's to buy Roche's Mexico unit for $59 m
IISCO-SAIL merger put to vote
Spentex acquires Tai textile unit
`Clear-cut policy must for meeting steel plants needs'
Panel mooted to study strengthening of SFIO
Thapar Group signs pact with Option Care for BPO foray
Cipla to ink deal with US co Akorn for anti-infective drug
Fan major Khaitan diversifies into fluorescent lamps
Toyota may set up next plant in Bangalore

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line